The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.
The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ...
Publications of the World Health Organization Home / Publications / Overview / Canada: A List of Essential Prescription Drugs and Related Products-Initial Recommendation 2025 (English)
This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by WHO fungal priority pathogens.
Alcohol and drugs are specifically mentioned under health target 3.5: “Strengthen the prevention and treatment of substance use, including narcotic drug abuse and harmful use of alcohol”.
How is the national opioid crisis impacting society? Will cannabis continue to become decriminalized? Can psychedelic medicine truly help psychological suffering? A new, one-of-a-kind degree program ...
MSN: Oyster larvae and addictive drugs: Study finds exposure affects behavior and survival rates
A study presented at the annual meeting of the Society for Risk Analysis in Washington, D.C., sheds light on the potential impacts of residual drug discharges on marine organisms. The findings suggest ...